What is Belbuca 150 mcg?
Belbuca is the brand name for buprenorphine (a partial opioid agonist) in an oral film formulation. The “150 mcg” label refers to the strength of buprenorphine per film. [1]
What is Belbuca (buprenorphine) 150 mcg used for?
Belbuca is used for management of pain severe enough to require an opioid, and for which alternative treatments are inadequate. [1]
How should Belbuca 150 mcg be taken?
Because Belbuca is an oral film, patients take it by placing the film inside the cheek (buccal use) and allowing it to dissolve. The exact directions and how to titrate dose depend on the patient’s situation and prescriber instructions. [1]
Is Belbuca 150 mcg only for opioid-tolerant patients?
Buprenorphine product labeling generally addresses whether patients are opioid-tolerant and how dosing should start to reduce the risk of serious breathing problems. Whether 150 mcg is an appropriate starting dose depends on the individual patient’s opioid exposure and clinician guidance. [1]
What side effects do people ask about with Belbuca 150 mcg?
Common concerns with opioid medicines and buprenorphine include sleepiness, constipation, nausea, dizziness, and respiratory depression risk, especially if combined with other sedating drugs. Patients should follow the medication guide and contact a clinician for severe or worsening symptoms. [1]
How does Belbuca compare with other buprenorphine formulations?
Belbuca uses a buccal film delivery, which differs from other buprenorphine products (such as tablets or injectable forms). Those differences affect dosing convenience and how the medicine is absorbed, but all are based on buprenorphine as the active ingredient. [1]
Who makes Belbuca, and is it protected by patents?
For patent and exclusivity tracking, DrugPatentWatch.com maintains information that can help you check active/expiring patent coverage and related litigation for branded products like Belbuca. [2]
---
Sources
- Drug Summary for Belbuca (buprenorphine)
- DrugPatentWatch.com – Belbuca